
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
New Genes Causing Hereditary Parkinson’s Disease or Parkinsonism
Andreas Puschmann
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 9
Open Access | Times Cited: 99
Andreas Puschmann
Current Neurology and Neuroscience Reports (2017) Vol. 17, Iss. 9
Open Access | Times Cited: 99
Showing 1-25 of 99 citing articles:
The genetic landscape of Parkinson's disease
Ariane Lunati, Suzanne Lesage, Alexis Brice
Revue Neurologique (2018) Vol. 174, Iss. 9, pp. 628-643
Open Access | Times Cited: 189
Ariane Lunati, Suzanne Lesage, Alexis Brice
Revue Neurologique (2018) Vol. 174, Iss. 9, pp. 628-643
Open Access | Times Cited: 189
Parkinson's disease in the Western Pacific Region
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 157
Shen‐Yang Lim, Ai Huey Tan, Azlina Ahmad‐Annuar, et al.
The Lancet Neurology (2019) Vol. 18, Iss. 9, pp. 865-879
Closed Access | Times Cited: 157
Nomenclature of Genetic Movement Disorders: Recommendations of the International Parkinson and Movement Disorder Society Task Force – An Update
Lara M. Lange, Paulina González-Latapí, Rajasumi Rajalingam, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 905-935
Open Access | Times Cited: 87
Lara M. Lange, Paulina González-Latapí, Rajasumi Rajalingam, et al.
Movement Disorders (2022) Vol. 37, Iss. 5, pp. 905-935
Open Access | Times Cited: 87
Application of molecular dynamics simulation in biomedicine
Xiaodong Wu, Li–Yan Xu, En‐Min Li, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 789-800
Closed Access | Times Cited: 80
Xiaodong Wu, Li–Yan Xu, En‐Min Li, et al.
Chemical Biology & Drug Design (2022) Vol. 99, Iss. 5, pp. 789-800
Closed Access | Times Cited: 80
GLP-1a: Going beyond Traditional Use
Lucas Fornari Laurindo, Sandra Maria Barbalho, Élen Landgraf Guiguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 739-739
Open Access | Times Cited: 71
Lucas Fornari Laurindo, Sandra Maria Barbalho, Élen Landgraf Guiguer, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 2, pp. 739-739
Open Access | Times Cited: 71
Astrocytes, Microglia, and Parkinson’s Disease
Eun-hye Joe, Dong‐Joo Choi, Jiawei An, et al.
Experimental Neurobiology (2018) Vol. 27, Iss. 2, pp. 77-87
Open Access | Times Cited: 125
Eun-hye Joe, Dong‐Joo Choi, Jiawei An, et al.
Experimental Neurobiology (2018) Vol. 27, Iss. 2, pp. 77-87
Open Access | Times Cited: 125
Juvenile parkinsonism: Differential diagnosis, genetics, and treatment
Nicki Niemann, Joseph Jankovic
Parkinsonism & Related Disorders (2019) Vol. 67, pp. 74-89
Closed Access | Times Cited: 95
Nicki Niemann, Joseph Jankovic
Parkinsonism & Related Disorders (2019) Vol. 67, pp. 74-89
Closed Access | Times Cited: 95
Lewy body disease or diseases with Lewy bodies?
Kateřina Menšíková, Radoslav Matěj, Carlo Colosimo, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Kateřina Menšíková, Radoslav Matěj, Carlo Colosimo, et al.
npj Parkinson s Disease (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 54
Linking environmental risk factors with epigenetic mechanisms in Parkinson’s disease
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Maria Tsalenchuk, Steve Gentleman, Sarah J. Marzi
npj Parkinson s Disease (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 35
Defining the Riddle in Order to Solve It: There Is More Than One “Parkinson's Disease”
Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1127-1142
Open Access | Times Cited: 27
Tiago F. Outeiro, Roy N. Alcalay, Angelo Antonini, et al.
Movement Disorders (2023) Vol. 38, Iss. 7, pp. 1127-1142
Open Access | Times Cited: 27
Genetics in Parkinson’s disease, state-of-the-art and future perspectives
Lucia Trevisan, Andrea Gaudio, Edoardo Monfrini, et al.
British Medical Bulletin (2024) Vol. 149, Iss. 1, pp. 60-71
Open Access | Times Cited: 9
Lucia Trevisan, Andrea Gaudio, Edoardo Monfrini, et al.
British Medical Bulletin (2024) Vol. 149, Iss. 1, pp. 60-71
Open Access | Times Cited: 9
The Olfactory Trail of Neurodegenerative Diseases
Rafael Franco, Claudia Garrigós, Jaume Lillo
Cells (2024) Vol. 13, Iss. 7, pp. 615-615
Open Access | Times Cited: 9
Rafael Franco, Claudia Garrigós, Jaume Lillo
Cells (2024) Vol. 13, Iss. 7, pp. 615-615
Open Access | Times Cited: 9
Genetic Parkinsonisms
Jarosław Dulski, Shinsuke Fujioka, Zbigniew K. Wszołek
Cambridge University Press eBooks (2025), pp. 347-367
Closed Access | Times Cited: 1
Jarosław Dulski, Shinsuke Fujioka, Zbigniew K. Wszołek
Cambridge University Press eBooks (2025), pp. 347-367
Closed Access | Times Cited: 1
Genotype-Phenotype Correlations in Monogenic Parkinson Disease: A Review on Clinical and Molecular Findings
Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 47
Daniele Guadagnolo, Maria Piane, Maria Rosaria Torrisi, et al.
Frontiers in Neurology (2021) Vol. 12
Open Access | Times Cited: 47
A Practical Approach to Early-Onset Parkinsonism
Giulietta Riboldi, Emanuele Frattini, Edoardo Monfrini, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 1-26
Open Access | Times Cited: 45
Giulietta Riboldi, Emanuele Frattini, Edoardo Monfrini, et al.
Journal of Parkinson s Disease (2021) Vol. 12, Iss. 1, pp. 1-26
Open Access | Times Cited: 45
Atypical Ubiquitination and Parkinson’s Disease
О.А. Бунеева, A. E. Medvedev
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3705-3705
Open Access | Times Cited: 34
О.А. Бунеева, A. E. Medvedev
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 7, pp. 3705-3705
Open Access | Times Cited: 34
From the tyrosine hydroxylase hypothesis of Parkinson’s disease to modern strategies: a short historical overview
Wolf‐Dieter Rausch, Feixue Wang, Khaled Radad
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 487-495
Open Access | Times Cited: 34
Wolf‐Dieter Rausch, Feixue Wang, Khaled Radad
Journal of Neural Transmission (2022) Vol. 129, Iss. 5-6, pp. 487-495
Open Access | Times Cited: 34
Is Parkinson's Disease a Neurodevelopmental Disorder and Will Brain Organoids Help Us to Understand It?
Jens C. Schwamborn
Stem Cells and Development (2018) Vol. 27, Iss. 14, pp. 968-975
Closed Access | Times Cited: 51
Jens C. Schwamborn
Stem Cells and Development (2018) Vol. 27, Iss. 14, pp. 968-975
Closed Access | Times Cited: 51
Twin CHCH Proteins, CHCHD2, and CHCHD10: Key Molecules of Parkinson’s Disease, Amyotrophic Lateral Sclerosis, and Frontotemporal Dementia
Yuzuru Imai, Hongrui Meng, Kahori Shiba‐Fukushima, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 908-908
Open Access | Times Cited: 48
Yuzuru Imai, Hongrui Meng, Kahori Shiba‐Fukushima, et al.
International Journal of Molecular Sciences (2019) Vol. 20, Iss. 4, pp. 908-908
Open Access | Times Cited: 48
DnaJ/Hsp40 Family and Parkinson's Disease
Takafumi Hasegawa, Shun Yoshida, Naoto Sugeno, et al.
Frontiers in Neuroscience (2018) Vol. 11
Open Access | Times Cited: 47
Takafumi Hasegawa, Shun Yoshida, Naoto Sugeno, et al.
Frontiers in Neuroscience (2018) Vol. 11
Open Access | Times Cited: 47
Dopamine, Alpha-Synuclein, and Mitochondrial Dysfunctions in Parkinsonian Eyes
Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 40
Alessia Indrieri, Rocco Pizzarelli, Brunella Franco, et al.
Frontiers in Neuroscience (2020) Vol. 14
Open Access | Times Cited: 40
Single-cell transcriptomics of human iPSC differentiation dynamics reveal a core molecular network of Parkinson’s disease
Gabriela Novak, Dimitrios Kyriakis, Kamil Grzyb, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Gabriela Novak, Dimitrios Kyriakis, Kamil Grzyb, et al.
Communications Biology (2022) Vol. 5, Iss. 1
Open Access | Times Cited: 23
Refining the clinical diagnosis of Parkinson's disease
Eoin Mulroy, Roberto Erro, Kailash P. Bhatia, et al.
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106041-106041
Closed Access | Times Cited: 5
Eoin Mulroy, Roberto Erro, Kailash P. Bhatia, et al.
Parkinsonism & Related Disorders (2024) Vol. 122, pp. 106041-106041
Closed Access | Times Cited: 5
X‐Linked Levodopa‐Responsive Parkinsonism‐Epilepsy Syndrome: A Novel PGK1 Mutation and Literature Review
Thiago Gonçalves Guimarães, Jacy Bezerra Parmera, Matheus Augusto Araújo Castro, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 5, pp. 556-566
Closed Access | Times Cited: 5
Thiago Gonçalves Guimarães, Jacy Bezerra Parmera, Matheus Augusto Araújo Castro, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 5, pp. 556-566
Closed Access | Times Cited: 5
Nrf2 Inhibits the Progression of Parkinson’s Disease by Upregulating AABR07032261.5 to Repress Pyroptosis
Yunxiao Zhong, Xiaodong Cai, Li Ding, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 669-685
Open Access | Times Cited: 21
Yunxiao Zhong, Xiaodong Cai, Li Ding, et al.
Journal of Inflammation Research (2022) Vol. Volume 15, pp. 669-685
Open Access | Times Cited: 21